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This paper presents the analysis of the 
autonomic nervous system (ANS) control and 
cardiac baroreflex sensitivity in patients 
undergoing general anesthesia for major surgery, 
with the goal of evaluating the effects of 
anesthesia bolus induction with propofol on 
autonomic control of heart rate (HR) and arterial 
blood pressure (ABP). The decrease in baroreflex 
gain observed through two different methods in the 
LF band suggests that baroreflex responses could 
be impaired by propofol during anesthesia. 
 
Keywords Baroreflex sensitivity, anesthesia, heart rate 
variability, blood pressure variability. 
1 Introduction 
The evaluation of the baroreflex (BR) gain is 
considered an important tool in clinical practice and 
gives a valuable measure of cardiovascular (CV) 
regulation in physiological and disease states, because 
BR represents the capability of the cardiovascular 
system to modify heart frequency in response to 
fluctuations of blood pressure [1]. 
The identification and quantification of adaptations to 
anesthetics responses and to surgical maneuvers may be 
relevant in the prevention of adverse cardiovascular and 
cardiorespiratory events, which lead to a better patient 
recovery or increasing survival chances. General 
anesthetic drugs are known to have direct effects on 
vascular tone and myocardial contractility, but little is 
known about how they influence CV regulation of 
neural and non neural origin, especially considering the 
potential side effects of general anesthetic agents, which 
can be serious and potentially life-threatening, 
particularly in very critically ill patients [2,3]. 
Despite the importance of understanding the 
underlying physiological mechanism and its clinical 
value, few studies in the literature quantify the effect of 
anesthetic drugs on the alteration of CV control under 
general anesthesia. 
Some authors [4,5] have analyzed baroreflex 
responses under propofol anesthesia, reporting that 
central sympatholytic and/or vagotonic mechanisms 
enable low heart rate to be sustained despite low blood 
pressure. These results were interpreted as a “resetting” 
of the baroreflex, but no impairment of BRS was 
demonstrated. Other works have reported an inhibition 
of sympathetic nervous activity in the periphery and a 
decrease of baroreflex sensitivity in the same conditions 
[6,7,8,9]. Nevertheless, these studies have been carried 
out with healthy human volunteers or in minor surgeries 
with patients classified as ASA (American Society of 
Anesthesiologists) class I. 
In this work, baroreflex sensitivity (BRS) and 
autonomic control of heart rate (HR) and of arterial 
blood pressure (ABP) were assessed in patients 
undergoing general anesthesia for major surgery, in 
particular, during the bolus induction with propofol. 
Spectral analysis of HR and ABP variability was carried 
out as well, in order to determine possible shifts in the 
sympatho-vagal balance following propofol 
administration. 
2 Methods 
A. Data Collection 
Custom software was developed (termed “Global 
Collect”, Labview 2009© environment) in order to 
simultaneously acquire, interpret and visualize data. All 
devices perform internal A/D conversion and transmit 
data (RS232 interfaces) sampled at heterogeneous 
frequencies and packaged through proprietary protocols.  
Invasive ABP was measured via an arterial catheter 
placed in the brachial artery and recorded with the GE 
S/5 Avance Carestation © at a sample frequency of 100 
Hz. Surgeries were performed in the University Hospital 
Tor Vergata in Rome, Italy. The study was approved by 
the local Ethics Committee, and the patients gave their 
written, informed consent to participate. 
Data from eight patients undergoing major surgical 
procedures involving assisted ventilation (5 men and 3 
women, age 62.7 ± 9.4 years) were analyzed. Patients 
patients were not affected either by chronic hypertension 
or diabetes. Sedation was induced by a bolus of propofol 
(2mg/kg) and maintained by a total intravenous 
anesthesia (TIVA, 6-8 mg /(kg hr)). 
Proceedings of the 7th International Workshop on Biosignal Interpretation (BSI2012) 110
B. Pre-processing and Data Analysis 
Artifact free ABP signals were selected before and 
after a propofol bolus was administered to induce 
general anesthesia. In particular, three epochs were 
considered: 1) awake, i.e. period before induction, when 
patient is still conscious; 2) sedation, the immediate 
period after bolus injection; 3) post-intubation, i.e. the 
immediate period after intubation and concomitant start 
of mechanical ventilation. 
Beat-by-beat series of systolic arterial pressure (SAP), 
diastolic arterial pressure (DAP), mean arterial pressure 
(MAP), and pulse pressure (PP), were extracted. Heart 
period (HP) was assessed as the time interval between 
two consecutive DAP onsets and was used as a surrogate 
of RR intervals. The time series were pre-processed with 
an adaptive filter in order to remove artifacts or ectopic 
beats. Dickey-Fuller stationary test was employed to 
select 2 minute long subseries for each ABP derived 
variables and for each epoch. Beat-by-beat series were 
then detrended and resampled at 1 Hz, to obtain zero-
mean time series. Power spectral density was computed 
via autoregressive (AR) estimation and power in the 
high frequency band (HF, 0.15 < f < 0.4 Hz), low 
frequency band (LF, 0.04 < f < 0.15 Hz) and very low 
frequency band (VLF, f < 0.04 Hz) were calculated. 
BRS was assessed with several techniques, as follows: 
a) as power spectral ratio between spectra of SAP and 
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when the coherence between the two signals was > 
0.5 [10]. 
b) by means of Transfer Function H(f), with SAP as 
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where Sxx(f) is SAP spectrum and Sxy(f) is the cross 
spectrum between SAP and HP [11]. The average gain 
of the transfer function between SAP and RR was 
estimated in the frequency range where the coherence is 
high (≥0.5) in LF (BRS TF LF) and HF band (BRS TF 
HF). 
c) by means of the sequence method, which consists 
in identifying the sequences in which HP and SBP 
simultaneously increased (up sequence) or decreased 
(down sequence) over three or more beats. Both up and 
down sequences were considered baroreflex sequences 
if they consist at least of three consecutive beats 
exhibiting SAP–HP correlation higher than 0.8; 
additionally SAP and HP beat-to-beat changes must be 
at least of 1 mmHg and 4 ms, respectively [12]. For 
each baroreflex sequence the regression slope was 
estimated using linear regression analysis and all slopes 
were averaged to obtain the index of the baroreflex 
sensitivity. 
One-way analysis of variance (ANOVA) for 
repeated-measure and then post-hoc comparisons test 
were performed for each index. The comparison 
between epochs was determined with Student’s paired t-
test or Wilcoxon signed-rank test according to data 
distribution. Statistical significance was considered for 
two tailed p-values<0.05. 
3 Results 
A significant decrease in the mean values of SAP, 
DAP, MAP and PP during propofol induction and after 
the intubation was obtained with respect to awake 
period, mainly due to the vasodilator effect of the 
anesthetic agent (table 1). The mean value of HP did 
not show significant changes either after propofol 
induction or after intubation. 
Figure 1 shows the power spectral density (PSD) of 
HP and DAP variability series in a patient: an evident 
reduction in PSD after the propofol administration, and 
a marked respiratory peak during post-intubation epoch 
can be observed. Total power significantly decreased in 
HP, DAP and MAP time series from awake to both 
sedation and post-intubation epochs, while total power 
of SAP and PP signals showed only a significant 
decrease in post-intubation epoch in comparison with 
awake period (table 2).  
A significant decrease of LF and HF power was 
observed in sedation and post-intubation epochs in 
comparison with awake in HP and DAP variability 
series. As regard to SAP variability signals, a 
significant decrease in LF band in post-intubation epoch 
only was obtained (table 2).  
HF% of HP and SAP reported significant higher 
values in post-intubation epoch with respect to awake 
period; while no significant difference was reported in 
DAP variability series. LF% reported significant lower 
values during post-intubation epoch in comparison with 
awake in HP and SAP fluctuations time series. 
As compared to awake, the BRS assessed by α index 
showed a significant decrease after sedation for the LF 
band. A significant decrease in sedation and post-
intubation epoch was obtained as well by BRS 
estimated by TF method (figure 2).  
No significant changes of BRS in HF band were 
reported during sedation epoch. The sequence method 
did not show any significant differences amongst the 
three epochs. 
 
Table 1. Heart Period and Blood Pressure average values for 
each epoch 
  Awake Sedation Post-intubation 
HP (bpm) 69.5 ± 13.2 67.1 ± 13.0 65.3 ± 10.4 
SAP (mmHg) 147±20.5 113±25.2* 110±27.8* 
DAP  (mmHg) 70.2±10.7 60.2±8.5† 57.6±8.6† 
MAP  (mmHg) 97.1+11.5 78.2+12.1* 76.4+15.1* 
PP  (mmHg) 76.4±20.3 53.0±20.9* 52.5±23.4* 
Values are expressed as mean ± std . 
† Student t-test p value < 0.05 (vs awake) 
* Student t-test p value < 0.01  (vs awake) 
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Figure 1: HP and SAP time series and spectra of a single patient during awake, sedation and post-intubation epochs. Blue line and 
axes refer to HP signal; green ones to SAP signal. 
 
Table 2. Power Spectral indices of HP, SAP and DAP 






   
LF(ms2) 42075±29915 13629±25090* 4313±3841* 
HF(ms2) 22174±19837 6915±8410* 3963±2954* 
LF% 68.2±15.9 58.9±13.7 42.5±26.2* 
HF% 31.5±15.9 40.0±13.2 56.7±26.0* 
LF/HF 2.8±1.6 1.7±0.9 1.3±1.4* 
TP(ms2) 72079±45311 25085±42716* 9389±6094* 
SAP  
   LF(mmHg2) 517.0±318.3 328.5±469.9 136±190* 
HF(mmHg2) 594±968 326±735* 142.6±72.6 
LF % 61.5±21.3 70.1±17.7 36.8±21.3*§ 
HF % 38.3±21.3 29.6±17.8 63.0±21.3*§ 
LF/HF 2.3±1.5 3.3±2.0 0.8±0.9*§ 
TP(mmHg2) 1133±1138 733±1183 294±249* 
DAP  
   LF(mmHg2) 290±189 105±147* 47.7±68.1* 
HF(mmHg2) 342±700 155±408* 28.0±13.9* 
LF % 66.2±22.9 72.4±23.7 50.4±21.9 
HF % 33.6±22.9 27.5±23.7 49.5±21.9 
LF/HF 3.2±2.4 5.9±5.7 1.5±1.4§ 
TP(mmHg2) 665±812 285±532* 82.2±83.2* 
Values are expressed as mean ± std 
Wilcoxon signed-rank test * p-value < 0.05 (vs awake) 
Wilcoxon signed-rank test § p-value < 0.05 (vs sedation) 
4 Discussion and Conclusions  
The present study investigated the effects of propofol 
anesthesia in autonomic cardiovascular control. As 
expected, a significant decrease of ABP average values 
was obtained, which can be explained by the 
vasodilatatory effect of propofol. 
No changes in HP average values resulted by 
propofol induction, a finding similar to previous works 
[13, 14]. The maintenance in heart rate may depend also 
to the anesthetic dose. Indeed, Xu et. al. [15] reported 
that propofol mediated sympathetic depression in nerve-
intact animals requires a high dose of agent, whereas in 
intact and vagotomy animals, heart rate did not 
significantly change with a lower dose of anesthetic. 
Our results reported a significant decrease in LF 
power in DAP and SAP variability time series during 
sedation and post-intubation epochs (table 2). As ABP 
LF power reflects sympathetic activity on peripheral 
resistance, these results suggest that propofol induction 
may reduce sympathetic nervous modulation of 
peripheral vasculature, and this is consistent with the 
results reported by Ogawa [16] and with the attenuation 
in peripheral sympathetic outflow reported by Sellgreen 
[6]. 
As regard the fluctuations of HP, total power, LF and 
HF components decreased significantly after induction. 
Despite an unaffected average HP value, these analyses 
hint an attenuation of cardiac autonomic regulation 
induced by propofol anesthesia.  
The BRS analysis showed a reduction of baroreflex 
gain in the LF band from awake to sedation and post-
intubation epochs. This may suggest that the baroreflex 
responses and autonomic control were blunted to 
control HP at lower ABP values during the preparatory 
phase of surgical intervention, i.e. induction and 
sedation phase. 
In this study we have not considered the influence of 
respiratory input in the BRS analyses. However in 
future studies it could be interesting to include the 
respiratory activity, because it is well known that 
respiration also modulates heart rate trough the 
respiratory sinus arrhythmia mechanism [9]. Moreover, 
during positive mechanical ventilation the respiratory 
oscillations can mask ANS modulation and its effects 
should be filtered. 
These are preliminary results inherent to the effects of 
propofol induced anesthesia in patients not affected by 
chronic hypertension and diabetes. Further analyses are 
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still ongoing in particular with patients affected by 
chronic hypertension and diabetes, in order to study the 
influences of pathological alteration in autonomic and 




Figure 2: BRS assessed by α index, Transfer Function (TF) in 
LF and HF bands, and Sequence method during awake, 
sedation and post-intubation epochs. * marks significant 
differences (t-test p-value <0.05) with respect to awake epoch. 
In post-intubation period BRS in HF band was excluded due 
to mechanical ventilation affecting respiratory band. 
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